{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:15:52Z","timestamp":1758759352327,"version":"3.44.0"},"reference-count":0,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pigment Cell Melanoma Res"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Current NICE guidelines state that in high\u2010risk melanoma patients, imaging should not be offered before SLNB unless lymph node or distant metastases are suspected. Our experience has been that in patients with pT3b, pT4a and pT4b melanomas, the rate of management\u2010changing findings on axial imaging prior to SLNB was high and that \u2018stage before operating\u2019 is a better approach. We now offer full axial imaging as staging to all high\u2010risk melanoma patients prior to SLNB and advise other skin cancer MDTs to follow this approach.<\/jats:p>","DOI":"10.1111\/pcmr.13213","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T13:23:38Z","timestamp":1733232218000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High\u2010Risk Melanoma: Stage Before Operating"],"prefix":"10.1111","volume":"38","author":[{"given":"Stanislau","family":"Makaranka","sequence":"first","affiliation":[{"name":"Department of Plastic Surgery Nottingham University Hospitals NHS FT  Nottingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zon","family":"Oo","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery Nottingham University Hospitals NHS FT  Nottingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Pollock","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery Nottingham University Hospitals NHS FT  Nottingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,12,3]]},"container-title":["Pigment Cell &amp; Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pcmr.13213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T14:29:32Z","timestamp":1758724172000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pcmr.13213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1111\/pcmr.13213"],"URL":"https:\/\/doi.org\/10.1111\/pcmr.13213","archive":["Portico"],"relation":{},"ISSN":["1755-1471","1755-148X"],"issn-type":[{"type":"print","value":"1755-1471"},{"type":"electronic","value":"1755-148X"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"2024-04-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e13213"}}